Cada
Cada Health AG is a private Swiss fertility clinic in Zurich offering IVF, ICSI, IUI, fertility preservation, and preimplantation genetic testing for individuals and couples, with an in-house lab and a multi-specialist medical team.
- Company typePrivate
- Founded2022
- HeadquartersWinterthur, Switzerland
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Cada does
Cada Health AG (operating as Cada Kinderwunschklinik Zürich) is a private Swiss fertility clinic founded in 2022 and headquartered at Bellerivestrasse 36, 8008 Zürich, in the Seefeld district. The clinic provides a full suite of reproductive medicine services for individuals and couples, including IVF, ICSI, IUI, frozen embryo transfer, social freezing (egg and sperm freezing), and a complete preimplantation genetic testing portfolio (PGT-A, PGT-M, PGT-SR, plus carrier screening and PID), supported by an on-site IVF laboratory and a 7-day fertility analysis offering. Its medical team comprises 6 specialist physicians — including Dr. med. Michael Jemec, who brings 30 years of reproductive medicine experience — and a dedicated clinical embryologist (Nacho Landaburu) heading the IVF lab.
The business operates on a self-pay, professional-services revenue model: core treatments (IVF, ICSI, PID, Social Freezing) are paid out of pocket with transparent pricing and installment options, while fertility analysis can be billed through Swiss health insurance. A free initial consultation serves as the patient acquisition funnel, supported by online booking (appointment.cada.com), monthly educational webinars, and a gynecologist referral network. The clinic serves patients from across Switzerland (Zurich, Basel, Bern, Luzern) and internationally, with video consultations available for remote patients. Notable patient segments include women over 40 (treated up to age 44), women seeking fertility preservation, and same-sex female couples following the introduction of 'Marriage for All' in Switzerland.
The clinic holds the regulatory memberships and certifications required to operate in Swiss reproductive medicine — ESHRE, FMH, QUAAB, and SGRM — and reports pregnancy success rates in the top range of Swiss and European fertility clinics. In January 2024, Cada closed a funding round led by SICTIC, its first disclosed capital event, to support clinic operations. Cada is structured as an Aktiengesellschaft under Swiss law, operates as a single-site business, and has 11-50 employees.
Cada firmographics
Firmographics- Name
- Cada
- Legal name
- Cada Health AG
- Website
- https://cada.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cada Health AG is a private Swiss fertility clinic in Zurich offering IVF, ICSI, IUI, fertility preservation, and preimplantation genetic testing for individuals and couples, with an in-house lab and a multi-specialist medical team.
- Ownership category
- akta.pro rank
Cada industry classification
Industry- Product category
- Reproductive Medicine / Fertility Clinic Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
- akta.pro secondary industries
- Genetic & Prenatal Testing Laboratories (HLAFAMAH), Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
Keywords
Where Cada is headquartered
LocationHeadquarters
- HQ city
- Winterthur
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Cada business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- IVF and ICSI Treatments: In-vitro fertilization and intracytoplasmic sperm injection procedures as core fertility treatments. Revenue generated from medical procedures performed at the clinic.
- Genetic Testing (PID): Preimplantation diagnostics including PGT-A (chromosomal abnormalities), PGT-M (monogenic diseases), PGT-SR (chromosomal structure) to increase pregnancy success rates and reduce miscarriage risk.
- Social Freezing: Egg freezing services for women who wish to preserve fertility for future family planning.
- Sperm Freezing: Sperm freezing services for male fertility preservation.
- Fertility Analysis and Diagnostics: Fertility testing services for couples, women, and men including AMH testing. Results delivered within 7 days. Fertility analysis billed through health insurance.
- IUI (Intrauterine Insemination): Intrauterine insemination procedure for couples with fertility challenges.
- Hormone Therapy: Hormonal stimulation treatments to support fertility treatments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | One-time | Free Initial Consultation |
| Other | Pay-as-you-go | Self-Pay Fertility Treatments |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Cada product offering
Product offeringCore offering
Cada operates a fertility clinic in Zurich, Switzerland that provides assisted reproduction treatments (IVF, ICSI, IUI, Frozen Embryo Transfer), fertility preservation (Social Freezing for women, Sperm Freezing for men), and preimplantation genetic testing (PID/PGT-A/PGT-M/PGT-SR, Carrier Screening), supported by an in-house IVF laboratory and a team of reproductive medicine specialists. Diagnostic services include comprehensive fertility analysis with results delivered within 7 days for couples, women, and men, alongside AMH testing and specialized diagnostics for PCOS and endometriosis. All services are anchored by a free initial consultation and delivered under an integrated one-roof clinic model.
Product overview
Cada is a fertility clinic in Zurich, Switzerland offering a comprehensive portfolio of assisted reproduction treatments and genetic testing services. The clinic provides a unified treatment platform combining core procedures (IVF, ICSI, IUI, FET) with fertility preservation options (Social Freezing, Sperm Freezing) and advanced genetic testing services (PID, PGT-A, PGT-M, PGT-SR, Carrier Screening). Supporting services include fertility analysis for couples/women/men, AMH testing, hormone therapy, and specialized diagnostics for PCOS and endometriosis. All services are delivered through an integrated clinic model with in-house laboratory, medical specialists, and free initial consultations.
Differentiator
Problem solved
Functional benefit
Products and services
- In-vitro-Fertilisation (IVF) In-vitro fertilization in which a woman's eggs are fertilized with the partner's sperm in a laboratory to achieve pregnancy. Performed on-site at Cada's Zurich clinic using the integrated IVF laboratory.
- ICSI (Intracytoplasmic Sperm Injection) A specialized form of IVF in which a single sperm is injected directly into an egg in the laboratory. Indicated for severe male factor infertility and performed in Cada's on-site embryology lab.
- IUI (Intrauterine Insemination) Intrauterine insemination in which partner (or donor) sperm is transferred into the uterus at ovulation time. Used for couples with less severe fertility challenges.
- Frozen Embryo Transfer (FET) Transfer of previously frozen embryos into the uterus following IVF/ICSI treatment, enabling deferred pregnancy attempts and use of surplus embryos.
- Social Freezing (Egg Freezing) Elective egg freezing that allows women to preserve fertility for future family planning, independent of a medical indication. Performed and stored at the Zurich clinic.
- Sperm Freezing Sperm cryopreservation service for men who wish to preserve fertility, for example prior to medical treatments affecting fertility, for career timing reasons, or for delayed family planning.
- PID (Preimplantation Diagnostics) Preimplantation genetic diagnosis for medical indication, examining embryos for genetic changes to increase the chance of successful pregnancy and reduce miscarriage risk.
- PGT-A (Preimplantation Genetic Testing – Aneuploidy) Genetic testing to detect chromosomal abnormalities (aneuploidies) in embryos created via IVF/ICSI, intended to improve implantation success and reduce miscarriage risk.
- PGT-M (Preimplantation Genetic Testing – Monogenic) Genetic testing specifically designed to prevent the transmission of monogenic hereditary diseases to offspring.
- PGT-SR (Preimplantation Genetic Testing – Structural Rearrangements) Genetic testing to examine chromosomal structural rearrangements in embryos, applicable for carriers of balanced translocations or inversions.
- Carrier Screening Genetic risk assessment to identify potential hereditary conditions in prospective parents at an early stage, before conception or treatment.
- Fertility Analysis (Fruchtbarkeitsanalyse) Comprehensive fertility analysis for couples, women, and men providing diagnostic results within 7 days, typically billed through health insurance.
- AMH Value Analysis Anti-Müllerian hormone analysis used to assess a woman's ovarian egg reserve as part of fertility diagnostics.
- Hormone Therapy (Hormonbehandlung) Hormonal stimulation treatment to support fertility treatments such as IVF, ICSI, and IUI, including cycle preparation and ovulation induction.
- PCOS Diagnostics Specialized diagnostic work-up for women with suspected or known Polycystic Ovary Syndrome, supporting fertility treatment planning.
- Endometriosis Diagnostics (Endotest) Comprehensive, individualized endometriosis testing using the Endotest, supporting diagnosis of one of the leading causes of infertility in women.
- Free Initial Consultation (Kostenfreie Erstberatung) No-cost initial consultation to discuss medical history, questions, and personal fertility situation, typically followed by a recommendation for fertility analysis and individualized treatment plan.
Quantifiable outcome
- Pregnancy rates per cycle and patient in highest range of Swiss and European fertility clinics
- +1 more outcomes
Companies that use Cada
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
Cada technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Cada partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- ESHRE (European Society of Human Reproduction and Embryology)coreCada is a member of ESHRE, a leading European association for reproductive medicine. Membership indicates adherence to the highest medical standards and participation in the professional community advancing fertility treatment practices.
- FMH (Foederatio Medicorum Helveticorum)coreCada is a member of FMH, the Swiss Medical Association. This membership ensures compliance with Swiss medical standards and regulations.
- QUAABcoreCada holds QUAAB certification, a quality certification for fertility clinics. This certification stands for highest medical standards and optimal treatment outcomes.
- SGRM (Swiss Society for Reproductive Medicine)coreCada is a member of SGRM, the Swiss professional society for reproductive medicine. Membership demonstrates adherence to national standards and best practices in fertility treatment.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Cada competitors and assessment
Company assessmentDirect peers
- Procrea: Long-established Swiss fertility clinic in Lugano offering IVF, ICSI, PGT, and fertility preservation. Most direct geographic competitor within Switzerland, mirroring Cada's integrated specialist-plus-lab model and self-pay positioning in the same regulatory environment.
- GYN-A.R.T. Geneva-based reproductive medicine center providing IVF, ICSI, fertility preservation, and genetic testing to Swiss and international patients. Direct Swiss peer operating the same clinical product portfolio under similar regulatory and reimbursement conditions.
- Centre de Procréation Médicalement Assistée (CPMA) Lausanne: Major Swiss fertility center at CHUV/Lausanne offering the full suite of ART and PGT services. Comparable full-service model with strong academic affiliation, directly competing for French-speaking and cross-border patients Cada also targets.
- Universitätsspital Zürich – Klinik für Reproduktionsmedizin: University hospital reproductive medicine department offering IVF, ICSI, and PGT in the same Zurich market. Largest local competitor by institutional scale, providing academic credibility that pressures private clinics on outcomes and referrals.
- CREATE Fertility: UK fertility clinic chain with an integrated specialist-and-lab model and strong emphasis on natural/mild IVF. Comparable in clinic-led GTM, self-pay positioning, and digital patient acquisition, serving as a useful benchmark for Cada's growth trajectory.
- CRGH (Centre for Reproductive and Genetic Health): London-based private fertility clinic offering IVF, ICSI, PGT, and fertility preservation with in-house genetics. Closest UK analog to Cada in combining reproductive medicine, genetics, and high clinical success rates in a premium urban setting.
Broad incumbents
- IVI – RMA Global: World's largest fertility clinic network with hundreds of clinics across Europe, the Americas, and the Middle East. Broader incumbent providing IVF, ICSI, PGT, and egg freezing at scale; relevant for benchmarking unit economics and expansion playbooks Cada may follow.
- The Fertility Partnership (TFP): European network of fertility clinics offering the full ART and PGT menu with self-pay and partnership models. Comparable in clinic-led delivery and genetic testing integration; broader footprint but overlapping clinical offering with Cada.
- CCRM Fertility: US-based fertility clinic network known for high success rates, advanced PGT, and integrated lab services. Comparable in positioning around clinical outcomes and genetic testing, but operates at significantly greater scale across multiple US metro markets.
- Boston IVF: Large US fertility clinic network within the IVI-RMA family offering IVF, ICSI, PGT, and fertility preservation. Comparable service breadth and self-pay orientation, relevant for benchmarking expansion potential that Cada may pursue within Switzerland.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Cada social profiles
Digital presenceCada compliance and trust
Trust signalCompliance4 records
Cada financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cada leadership team
Management profileNumber of profiles
Profiles7 records
Cada funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cada M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cada
What does Cada do?
Cada operates a fertility clinic in Zurich, Switzerland that provides assisted reproduction treatments (IVF, ICSI, IUI, Frozen Embryo Transfer), fertility preservation (Social Freezing for women, Sperm Freezing for men), and preimplantation genetic testing (PID/PGT-A/PGT-M/PGT-SR, Carrier Screening), supported by an in-house IVF laboratory and a team of reproductive medicine specialists. Diagnostic services include comprehensive fertility analysis with results delivered within 7 days for couples, women, and men, alongside AMH testing and specialized diagnostics for PCOS and endometriosis. All services are anchored by a free initial consultation and delivered under an integrated one-roof clinic model.
Is Cada a public or private company?
Cada is a private company. It is classified as venture growth investor backed and is currently operating.
When was Cada founded?
Cada was founded in 2022. It employs 11 to 50 people.
Where is Cada based?
Cada is headquartered in Winterthur, Switzerland, in the Europe region.
How does Cada make money?
Seven revenue lines are on record. IVF and ICSI Treatments are the primary driver. The others are genetic Testing (PID), social Freezing, sperm Freezing, fertility Analysis and Diagnostics, IUI (Intrauterine Insemination) and hormone Therapy.
Who are Cada's main competitors?
Direct peers on record are Procrea, GYN-A.R.T., Centre de Procréation Médicalement Assistée (CPMA) Lausanne, Universitätsspital Zürich – Klinik für Reproduktionsmedizin, CREATE Fertility and CRGH (Centre for Reproductive and Genetic Health). Broad incumbents are IVI – RMA Global, The Fertility Partnership (TFP), CCRM Fertility and Boston IVF.
Does Cada have an API?
No public API is recorded for Cada.
What industry is Cada in?
Cada's product category is Reproductive Medicine / Fertility Clinic Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.